Pfizer is moving ahead with its new COVID-19 pill, seeking emergency use authorization in the US and inking a licensing deal to allow 95 lower-income countries access to generic versions of the medication.  

When ProPublica investigated an outbreak of a multidrug-resistant salmonella called infantis that has sickened tens of thousands of people in the US, it deployed the usual “bread and butter” interviews and public records requests. It also rolled out a novel tool: genomic…

In the absence of vaccines and in the throes of a vicious second wave of COVID-19 in January, desperate South Africans turned to an unproven drug: ivermectin.   The antiparasitic drug has been used by millions of people around the world trying to prevent and treat COVID-19—…

COVID-19 has “exposed some things that are unsightly about us as a society”—including selfishness and an unwillingness “to sacrifice personal privilege for communal safety,” said Pastor Howard-John Wesley, DMin, of Alexandria, Virginia’s Alfred Street Baptist Church at…

“A village vanishes daily in Romania!” declares Catalin Cirstoiu, head of the Bucharest University Emergency Hospital, AP reports.    In recent weeks, Romania has reported the world’s highest per-capita COVID-19 death rate, The New York Times reports.  

In a North Korean hospital, 10 patients with COVID-19 symptoms were sent to an unheated ward typically used to treat tuberculosis, Radio Free Asia reports; they later died amid freezing temperatures.   The hospital, in Chongjin, then falsified the cause of their deaths—…

Things aren’t going quite as promised at the CDC under Rochelle Walensky, who pledged to fix the embattled agency.   It was an ambitious goal for the stunningly successful researcher and political outsider.   She’s made some blatant missteps (including asserting that…

As country representatives continue to negotiate gritty details of agreements at the COP26 UN climate conference, WHO announced today that 50 countries have committed to building climate-resilient and low-carbon health systems. 

African scientists are working hard to test new drugs against COVID-19 that would also be affordable, but they are running into significant challenges, Nature reports.   Why new drugs are needed:

Tedros Adhanom Ghebreyesus is poised to serve a second term as the WHO chief—he’s the sole nominee for the top job, according to Western diplomats.   Among the supporters: France, Germany and other EU members, plus 3 African countries—Botswana, Kenya and…